<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>FI-3-2020-2019000746</iati-identifier>
  <reporting-org ref="FI-3" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Ministry for Foreign Affairs of Finland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Gavi The Vaccine Alliance</narrative>
   <narrative xml:lang="FI">Rokotusliittouma Gavi; COVAX AMC</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Gavi the Vaccine Alliance promotes global immunisation against epidemics and helps vaccinate children against life-threatening infectious diseases. Gavi vaccinates almost half of the world?s children. Gavi&apos;s support has contributed to the vaccination of mo
re than 760 million unique children through routine immunisation. Gavi enhances the access to routine immunisation of those children who are in the most vulnerable position. Gavi helps decrease child mortality: the increase in immunisation has helped halve
 childhood mortality by preventing approximately 13 million deaths. Gavi has a remarkable role in strengthening primary health care (PHC) bringing us closer to the Sustainable Development Goal 3 of Universal Health Coverage (UHC) ensuring that no one is le
ft behind.Vaccinating children advances the status and health of girls and has an impact on women&apos;s status and health as well because women are principally those who take care of ill relatives and also themselves are exposed to the disease. Gavi supports v
accination of girls against human papillomavirus (HPV). HPV is the main cause of cervical cancer.According to Gavi vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime. A
s children become healthier they their families communities and countries are more able to be economically prosperous and socially stable.Gavi&apos;s work improves global health security by helping countries broaden vaccine coverage and improve their health sys
tems. This makes them less susceptible and better able to prevent disease outbreaks that pose a threat to people in these countries protecting millions of others around the world.Gavi?s core partners are the World Health Organization UNICEF the World Bank 
and the Bill + Melinda Gates Foundation.</narrative>
   <narrative xml:lang="FI">Rokotusliittouma Gavi edistaa globaalia rokotesuojaa ja lasten rokottamista hengenvaarallisia tartuntatauteja vastaan. Gavin paamissiona on pelastaa ihmishenkia ja turvata ihmisten terveys lisaamalla rokotteiden yhdenvertaista ja kestavaa kayttoa tarjoamal
la koyhille maille rokotteet matalalla hinnalla ja samalla sitouttamalla kehitysmaat sisallyttamaan rokotusohjelmat terveydenhoitojarjestelmaansa. Gavilla on merkittava rooli perusterveydenhuollon ja terveysjarjestelmien vahvistamisen saavuttamisessa SDG 3
:n (terveys ja hyvinvointi) mukaisesti. Toiminnallaan Gavi edistaa Agenda 2030:n keskeista periaatetta kaikista haavoittuvimpien ryhmien auttamiseksi. Vaikka COVAX AMC ei suoraan edista mitaan Suomen kehityspolitiikan erityisista painopisteista on sen tuke
minen keskeista rokotteiden yhdenvertaisen saatavuuden toteutumiseksi osana koronapandemian ratkaisua ja kehitysmaiden tilanteen turvaamista.COVID-19 -rokotteiden laakkeiden ja diagnostiikan tutkimuksen kehittamisen ja globaalin saatavuuden varmistamiseksi
 on kehitetty Access to COVID-19 Tools (ACT) Accelerator -aloitteen rokotepilari COVAX Facility (COVAX) joka toimii hallinnollisesti Gavin yhteydessa. Gavilla on keskeinen rooli koronapandemiaan vastaamisen nakokulmasta ja silla on yhdessa Maailman terveys
jarjesto WHO:n ja epidemiavalmiusinnovaatiokoalitio CEPI:n kanssa johtorooli COVAX-mekanismissa. COVAX on paaasiallinen kanava kansainvaliselle yhteistyolle COVID-19-rokotteiden yhdenvertaisen saatavuuden varmistamiseksi ja myos EU:n rokotesolidaarisuuden 
toteuttamiselle. Tuki kohdennetaan Gavin hallinnoiman COVID-19 Advanced Market Commitment (COVAX AMC) -yhteistyomekanismille jonka kautta tuetaan COVAX Facilityyn kuuluvan 92 matalan tulotason ja keskitulotason maiden turvallisten ja tehokkaiden COVID-19 -
rokotteiden saatavuutta.</narrative>
  </description>
  <participating-org ref="FI-3" role="1" type="10">
   <narrative xml:lang="EN">Ministry for Foreign Affairs of Finland</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">The Gavi Alliance</narrative>
  </participating-org>
  <other-identifier ref="FI-3-2019-2019000746" type="A3"></other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-10-22" type="2">
   <narrative xml:lang="EN">Actual start date of the activity</narrative>
  </activity-date>
  <activity-date iso-date="2020-12-31" type="3">
   <narrative xml:lang="EN">Planned end date of the activity</narrative>
  </activity-date>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="2" vocabulary="99" vocabulary-uri="https://um.fi/documents/35732/48132/human_rights_based_approach_in_finlands_development_cooperation___guidance">
   <narrative xml:lang="EN">Human rights sensitive</narrative>
   <narrative xml:lang="FI">Ihmisoikeudet huomioiva</narrative>
  </tag>
  <tag code="2430664" vocabulary="99" vocabulary-uri="https://um.fi/documents/35732/0/finlands-development-cooperation-appropriations-and-disbursements-1989-2019.pdf/fe42e62c-798c-359f-6180-e7e01fd9d89a?t=1588088517786">
   <narrative xml:lang="FI">Maittain kohdentamaton kehitysyhteistyo</narrative>
   <narrative xml:lang="EN">Non-region specific development cooperation</narrative>
  </tag>
  <tag code="3.8" vocabulary="3"></tag>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="B02" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="EUR" value-date="2020-01-01">2500000</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-10-22"></transaction-date>
   <value currency="EUR" value-date="2020-01-01">2500000</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-17"></transaction-date>
   <value currency="EUR" value-date="2020-01-01">2500000</value>
  </transaction>
  <related-activity ref="FI-3-2019-2019000746" type="1"></related-activity>
 </iati-activity>
</iati-activities>
